TOTH A ERNEST JR — SEC Form 4 filings
SEC reporting owner CIK 1280273. 6 Form 4 filings on record with FilingPulse; latest filed 2026-05-07.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-03-11 to 2026-05-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 58,254 shares, $243,094 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
- Largest priced transaction: sale of 58,254 shares @ $4.17 ($243,094) in Aquestive Therapeutics, Inc., filed 2026-03-11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | Chief Financial Officer | 6 | — | 1 leg · 58,254 sh · $243,094 | 11 |
Form 4 filings — TOTH A ERNEST JR
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-07 | 4 | Aquestive Therapeutics, Inc. (AQST) | Tax withholding (F): 92,652 @ $4.18 | EDGAR |
| 2026-04-13 | 4 | Aquestive Therapeutics, Inc. (AQST) | Grant/award (A): 82,500 (derivative) @ $0 | EDGAR |
| 2026-03-11 | 4 | Aquestive Therapeutics, Inc. (AQST) | Grant/award (A): 95,000 @ $0 · Sale (S): 58,254 @ $4.17 · Grant/award (A): 70,000 (derivative) @ $0 | EDGAR |
| 2025-03-11 | 4 | Aquestive Therapeutics, Inc. (AQST) | Grant/award (A): 110,000 @ $0 · Tax withholding (F): 10,193 @ $2.65 · Tax withholding (F): 8,736 @ $2.65 · Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2024-03-12 | 4 | Aquestive Therapeutics, Inc. (AQST) | Tax withholding (F): 11,705 @ $4.88 | EDGAR |
| 2024-03-11 | 4 | Aquestive Therapeutics, Inc. (AQST) | Grant/award (A): 120,000 @ $0 · Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1280273 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →